from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0052/-

LFCtreatmentdescriptionclass of inhibitor

-0.692

Amikacinug/mL Amikacintranslation

-0.424

Cap5-10ug/mL Capreomycintranslation

0.560

Rox10-50 ug/mL Roxithromycintranslation

-0.045

SM2-5 ug/mL Streptomycintranslation

-0.671

Tet5-10 ug/mL Tetracyclinetranslation

0.673

Rif0.2-5ug/mL Rifampicintranscription

0.468

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.528

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.965

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.153

CPZ10-50 ug/mL Chlorpromazinerespiration

0.662

Clofazimine10-13 ug/mL Clofaziminerespiration

0.093

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.562

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.876

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.211

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.311

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.465

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.237

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.265

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.334

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.741

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.293

Nigericin50 uM Nigericinrespiration

0.390

TRC10-150 ug/mL Triclosanrespiration

0.486

TRZ10-25 ug/mL Thioridazinerespiration

-1.607

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.144

menadione6-10 ug/mL Menadionerespiration

-0.745

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.398

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.341

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.457

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.576

NRP_1Non-replicating persistence stage 1dosRassociated

0.166

Amp0.2mg/mL AmpicillincellWall

0.195

Cephalexin20-100 ug/mL CephalexincellWall

0.180

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.323

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.050

EMB10-20 ug/mL EthambutolcellWall

0.167

Eta12-40 ug/mL EthionamidecellWall

-0.039

INH0.2-0.4 ug/mL IsoniazidcellWall

0.092

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.173

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.638

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.115

BZA0.12 mg/mL BenzamidearomaticAmides

0.235

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.155

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.196

H2O24 mM hydrogen peroxideDNAdamaging

0.048

Levo10 ug/mL LevofloxacinDNAdamaging

0.326

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.906

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.582

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.087

UVUV-irradiationDNAdamaging

-1.542

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.242

Antimycin12.5-50 ug/mL Antimycin A?

0.457

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.882

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.847

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.078

PA8240.2-2 ug/mL PA-824?

-0.250

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.137

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.416

mercaptoethanol2 mM 2-Mercaptoethanol?

0.066

methoxatin10-20 ug/mL Methoxatin?